Pharmaceutical Dosing Errors at a Pediatric HIV Clinic in Mwanza, Tanzania

Neel Mahesh Naik1, Ruth Nicholas Mbwanji, Mwajuma Mgawe

  • 1From the *Department of Pediatrics, Baylor College of Medicine, Houston, Texas; and †Baylor College of Medicine Children's Foundation - Tanzania, Paediatrics, Mwanza, Tanzania.

Insights

Pediatric HIV medication dosing errors occurred at 1 in 34 prescriptions in Tanzania. Young children faced the highest risk due to growth-related dose adjustments and limited medication availability, necessitating improved prescription practices.

Area of Science:

  • Pediatric HIV/AIDS Management
  • Medication Safety
  • Global Health Pharmacy Practice

Background:

  • Outpatient medication dosing errors pose a significant risk in pediatric care.
  • Accurate dosing is critical for managing chronic conditions like HIV in children.
  • Previous research indicates variability in pediatric medication dosing accuracy.

Purpose of the Study:

  • To determine the outpatient medication dosing error rate in a pediatric HIV clinic in Mwanza, Tanzania.
  • To identify specific patient groups and circumstances associated with higher dosing error risks.
  • To inform interventions aimed at improving medication safety for children with HIV.

Main Methods:

  • Retrospective analysis of outpatient prescriptions for pediatric patients with HIV.
  • Calculation of medication dosing error rates per prescription.
  • Identification of patient demographics and prescription patterns associated with errors.

Main Results:

  • The overall medication dosing error rate was approximately 1 in 34 prescriptions.
  • Young children were identified as the highest-risk group for dosing errors.
  • Errors were frequently observed at consecutive patient visits, suggesting potential issues with repeated prescription reviews.

Conclusions:

  • Significant rates of outpatient medication dosing errors exist in pediatric HIV care in this setting.
  • Pediatric-specific factors, including growth-related dose changes and formulation availability, contribute to errors.
  • Clinical practices, such as reordering without thorough double-checking, may exacerbate medication errors.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
340
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
457
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
388
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
47
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
328
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
293